LIPC-AS1

Across TCGA pan-cancer cohorts, LIPC-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LIPC-AS1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LIPC-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LIPC-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and THYM show a favorable association.

UCEC, BLCA, and LGG are the cancer types where LIPC-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.533	0.732	.001	94	view →
BLCA	OS	Median	All	0.540	0.349	.004	71	view →
LGG	DFS	Median	All	0.648	0.791	<.001	47	view →
THCA	OS	Quartile	All	0.947	1.000	.005	31	view →
ACC	OS	Tertile	All	0.205	0.728	.004	30	view →
THYM	OS	Tertile	All	1.000	0.747	.007	22	view →
GBM	OS	Quartile	All	0.269	0.458	.003	21	view →
KICH	OS	Median	III,IV	1.000	0.781	.011	19	view →
SKCM	OS	Tertile	IV	0.450	0.806	.040	18	view →
LIHC	DFS	Quartile	All	0.205	0.358	.024	12	view →
READ	DFS	Tertile	IV	0.295	0.657	.035	9	view →
SARC	OS	Quartile	All	0.812	0.529	.025	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LIPC-AS1–UCEC (OS)

Open the UCEC breakdown →